Faktor-faktor Prognostik Progression-Free Survival Dua Tahun pada pasien Limfoma Hodgkin di Rumah Sakit Umum Pusat Nasional Dokter Cipto Mangunkusumo = Prognostic Factors of Two-Year Progression-Free Survival in Hodgkin's Lymphoma patients at Doctor Cipto Mangunkusumo National Central General Hospital

Perbandingan rejimen kemoterapi Cisplatin Etoposide dengan Cisplatin-Docetaxel dalam hal kesintasan 2 tahun dan Progersion-Free Survival pasien Kanker Paru stadium lanjut jenis Non-Small Cell = Comparison of Chemotherapy effect between Cisplatin-Etoposide and Cisplatin-Docetaxel in 2 year survival rate and Progression-Free Survival rate of advanced Non-Small Cell Lung Cancer patients / Salman Paris Harahap

Hubungan Ekspresi Protein 16 (p16) dan Ki-67 dengan Progression-Free Survival 3 Tahun Pasien Kanker Nasofaring Stadium Lokal Lanjut Pasca Kemoradiasi Berbasis Platinum = Association of Ki67 and p16 expression with 3-years Progression-Free Survival of Locally Advanced Nasopharyngeal Carcinoma after Platinum-based Concurrent Chemoradiotherapy

Hubungan Antara Rasio Limfosit-Monosit, Tumor-Infiltrating Lymphocytes, dan Tumor-Associated Macrophages dengan Progression-Free Survival 3 Tahun Pasien Kanker Nasofaring Stadium Lokal Lanjut = The Association Between Lymphocyte-Monocyte Ratio, Tumour-Infiltrating Lymphocytes, and Tumour-Associated Macrophages with 3-Year Progression-Free Survival in Advanced Local Stage Nasopharyngeal Cancer Patients

Hubungan antara Jumlah Monosit Absolut, Tumor Associated Macrophage dan Tumor Infiltrating Lymphocytes terhadap Event Free Survival 2 Tahun pada Diffuse Large B-Cell Lymphoma yang mendapatkan terapi RCHOP = Correlation between Absolute Monocyte Count, Tumor-Associated Macrophage and Tumor Infiltrating Lymphocytes to Event Free Survival 2 years in Diffuse Large B-Cell Lymphoma receiving RCHOP therapy